Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

1.

Diversity versus concentration in antipsychotic drug selection.

Leslie DL, Rosenheck RA.

J Ment Health Policy Econ. 2008 Sep;11(3):107-12.

PMID:
18806300
[PubMed - indexed for MEDLINE]
2.

Benchmarking the quality of schizophrenia pharmacotherapy: a comparison of the Department of Veterans Affairs and the private sector.

Leslie DL, Rosenheck RA.

J Ment Health Policy Econ. 2003 Sep;6(3):113-21.

PMID:
14646004
[PubMed - indexed for MEDLINE]
3.

From conventional to atypical antipsychotics and back: dynamic processes in the diffusion of new medications.

Leslie DL, Rosenheck RA.

Am J Psychiatry. 2002 Sep;159(9):1534-40.

PMID:
12202274
[PubMed - indexed for MEDLINE]
4.

Variations in prescribing practices for novel antipsychotic medications among Veterans Affairs hospitals.

Owen RR, Feng W, Thrush CR, Hudson TJ, Austen MA.

Psychiatr Serv. 2001 Nov;52(11):1523-5.

PMID:
11684751
[PubMed - indexed for MEDLINE]
5.

Development and delivery of a quality improvement program to reduce antipsychotic polytherapy.

Gören JL, Beck SE, Mills BJ, Shtasel DL, Dufresne RL.

J Manag Care Pharm. 2010 Jul-Aug;16(6):393-401.

PMID:
20635830
[PubMed - indexed for MEDLINE]
Free Article
6.

Antipsychotic use in the treatment of outpatients with schizophrenia in the VA from fiscal years 1999 to 2006.

Sernyak MJ, Rosenheck RA.

Psychiatr Serv. 2008 May;59(5):567-9. doi: 10.1176/appi.ps.59.5.567.

PMID:
18451019
[PubMed - indexed for MEDLINE]
7.

Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.

Loosbrock DL, Zhao Z, Johnstone BM, Morris LS.

J Ment Health Policy Econ. 2003 Jun;6(2):67-75.

PMID:
14578539
[PubMed - indexed for MEDLINE]
8.

Aligning clinical practice to PTSD treatment guidelines: medication prescribing by provider type.

Abrams TE, Lund BC, Bernardy NC, Friedman MJ.

Psychiatr Serv. 2013 Feb 1;64(2):142-8. doi: 10.1176/appi.ps.201200217.

PMID:
23474508
[PubMed - indexed for MEDLINE]
9.

Prescribing of antipsychotic medication in a medicaid population: use of polytherapy and off-label dosages.

Kogut SJ, Yam F, Dufresne R.

J Manag Care Pharm. 2005 Jan-Feb;11(1):17-24.

PMID:
15667230
[PubMed - indexed for MEDLINE]
Free Article
10.

Clinical practice variations in prescribing antipsychotics for patients with schizophrenia.

Owen RR, Fischer EP, Kirchner JE, Thrush CR, Williams DK, Cuffel BJ, Elliott CE, Booth BM.

Am J Med Qual. 2003 Jul-Aug;18(4):140-6.

PMID:
12934949
[PubMed - indexed for MEDLINE]
11.

Clinicians' reasons for antipsychotic coprescribing.

Sernyak MJ, Rosenheck R.

J Clin Psychiatry. 2004 Dec;65(12):1597-600.

PMID:
15641863
[PubMed - indexed for MEDLINE]
12.

Impact of medical comorbidity on the quality of schizophrenia pharmacotherapy in a national VA sample.

Chwastiak L, Rosenheck R, Leslie D.

Med Care. 2006 Jan;44(1):55-61.

PMID:
16365613
[PubMed - indexed for MEDLINE]
13.

[Prescription practices of antipsychotic medication in early psychosis: a two-year follow-up survey of subjects admitted in two psychiatric hospitals of South-Western France].

Grolleau A, Cougnard A, Parrot M, Kalmi E, Desage A, Misdrahi D, Brun-Rousseau H, Verdoux H.

Encephale. 2007 May-Jun;33(3 Pt 1):326-31. French.

PMID:
17675930
[PubMed - indexed for MEDLINE]
14.
15.

Off-label use of antipsychotic medications in the department of Veterans Affairs health care system.

Leslie DL, Mohamed S, Rosenheck RA.

Psychiatr Serv. 2009 Sep;60(9):1175-81. doi: 10.1176/appi.ps.60.9.1175.

PMID:
19723731
[PubMed - indexed for MEDLINE]
16.

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G.

Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165.

PMID:
16707074
[PubMed - indexed for MEDLINE]
Free Article
17.

The effect of institutional fiscal stress on the use of atypical antipsychotic medications in the treatment of schizophrenia.

Leslie DL, Rosenheck R.

J Nerv Ment Dis. 2001 Jun;189(6):377-83.

PMID:
11434638
[PubMed - indexed for MEDLINE]
18.

From clinical trials to real-world practice: use of atypical antipsychotic medication nationally in the Department of Veterans Affairs.

Rosenheck R, Leslie D, Sernyak M.

Med Care. 2001 Mar;39(3):302-8.

PMID:
11242324
[PubMed - indexed for MEDLINE]
19.

Explicit versus implicit review to explore combination antipsychotic prescribing.

Wheeler A.

J Eval Clin Pract. 2009 Aug;15(4):685-91. doi: 10.1111/j.1365-2753.2008.01084.x.

PMID:
19674220
[PubMed - indexed for MEDLINE]
20.

Medical decision making in antipsychotic drug choice for schizophrenia.

Hamann J, Langer B, Leucht S, Busch R, Kissling W.

Am J Psychiatry. 2004 Jul;161(7):1301-4.

PMID:
15229068
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk